Skip to main content

Egrifta Prices, Coupons and Patient Assistance Programs

Egrifta (tesamorelin) is a member of the growth hormones drug class and is commonly used for Lipodystrophy.

Egrifta Prices

The cost for Egrifta subcutaneous powder for injection 2 mg is around $6,786 for a supply of 30 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Egrifta price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Subcutaneous Powder For Injection Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Egrifta Coupons and Rebates

Egrifta offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Egrifta SV Co-Pay Assistance Program: Eligible commercially insured patients may save on their prescriptions by enrolling in the program; contact a Patient Support Specialist for additional information at 833-238-4372.

Applies to:
Egrifta SV
Number of uses:
12 times within calendar year

Form more information phone: 833-238-4372 or Visit website

Patient Assistance Programs for Egrifta

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: THERA Patient Support Program

Elligibility requirements:
  1. Contact program for details.
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. The patient must be a US citizen or legal resident.
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Education and support services are available; Contact program for details.
Applicable drugs:
  • Egrifta SV (tesamorelin) Injection; Subcutaneous

More information please phone: 833-238-4372 Visit Website